Safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomised, first-in-human phase 1 study

Autor: Sivapalasingam, Sumathi, Kamal, Mohamed, Slim, Rabih, Hosain, Romana, Shao, Weiping, Stoltz, Randall, Yen, Joseph, Pologe, Laura G, Cao, Yuan, Partridge, Michael, Sumner, Giane, Lipsich, Leah
Zdroj: In The Lancet Infectious Diseases August 2018 18(8):884-893
Databáze: ScienceDirect